Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 ... microbiology and infection diagnostics driven by both the MALDI Biotyper and the newly acquired ELITech Molecular ...

The application of NGS in clinical laboratories has become increasingly widespread ... The prepared target plate was then inserted into the Bruker MALDI Biotyper system (Bruker Daltonics, Bremen, ...

About Medpace Holdings, Inc. and Bruker Corporation Medpace Holdings, Inc. provides clinical research-based drug and medical ... life science mass spectrometry; MALDI Biotyper rapid pathogen ...

Bruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat. Bruker ...

BILLERICA, Mass. (AP) — BILLERICA, Mass. (AP) — Bruker Corp. (BRKR) on Thursday reported fourth-quarter earnings of $13.7 million. The Billerica, Massachusetts-based company said it had profit ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

(3) Bruker Scientific Instruments (BSI) revenue reflects the sum of the BSI BioSpin, CALID and Nano Segments as presented in our Annual Report on Form 10-K for the year ended December 31 ...

Market Reaction Despite the earnings beat, Bruker's stock price fell by 0.77% in pre-market trading. The stock has been trading between a 52-week high of $94.86 and a low of $48.07, indicating ...